Undervalued Stocks Based On Cash Flows

Results

675

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

675 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
000630
CN¥7.933.5%150.9%CN¥102.6bCN¥5.0040.440.2%1.3%Materials
ACB
CA$4.22-0.7%-24.5%CA$257.1mCA$6.140.8121.6%n/aPharmaceuticals & Biotech
BSGR
€5.850%40.6%€492.4m€5.9615.227.7%3.2%Retail
CINT
SEK 5.72-0.5%-19.2%SEK 2.0bSEK 6.351.2113.5%n/aSoftware
DEZ
€9.898.6%44.5%€1.5b€12.9417.728.5%1.8%Capital Goods
002240
CN¥46.98-9.0%278.6%CN¥40.0bCN¥33.805.462.0%0%Materials
PLPL3
R$8.30-2.5%-43.4%R$1.7bR$20.565.024.4%5.9%Consumer Durables
141A
JP¥2,743.00-3.2%24.8%JP¥336.7bJP¥4,675.0036.230.5%0.6%Consumer Retailing
TPC
US$77.991.9%80.1%US$4.1bUS$113.2552.549.6%0.3%Capital Goods
TLGO
€2.63-1.9%-13.4%€355.3m€3.360.6140.7%0%Capital Goods
SOHO
UK£0.754.3%6.6%UK£300.6mUK£0.930.871.4%7.5%Real Estate
TFII
CA$204.21-9.0%68.7%CA$16.9bCA$212.6739.728.6%1.3%Transportation
7199
JP¥1,973.003.1%-4.6%JP¥73.8bJP¥4,200.0012.615.9%3.2%Diversified Financials
1801
HK$75.35-2.6%-4.5%HK$132.4bHK$117.58139.231.1%n/aPharmaceuticals & Biotech
NEXAM
SEK 3.13-1.6%-18.7%SEK 321.3mSEK 3.501.763.3%n/aMaterials
ABBV
US$216.49-2.3%17.8%US$382.5bUS$253.55106.425.4%3.2%Pharmaceuticals & Biotech
000426
CN¥43.016.8%181.3%CN¥70.3bn/a28.621.7%0.3%Materials
NCC B
SEK 194.701.3%5.2%SEK 19.0bSEK 220.00207.048.7%4.6%Capital Goods
8046
NT$862.000.2%701.9%NT$564.7bNT$897.45182.759.5%0.2%Tech
HSHP
NOK 134.20-6.2%113.0%NOK 6.3bNOK 136.3222.418.9%6.9%Transportation
4776
JP¥2,295.00-2.7%-32.9%JP¥107.1bJP¥4,000.0014.212.9%2.2%Software
ENEA
SEK 75.00-8.5%11.4%SEK 1.4bSEK 92.5016.223.7%0%Software
RHM
€1,203.40-0.2%-31.5%€54.9b€1,882.1053.330.8%1.0%Capital Goods
ARML3
R$3.00-6.3%-22.3%R$1.0bR$6.0920.555.3%20.6%Capital Goods
Page 1 of 19